Synthetic Combinatorial Libraries as an Alternative Strategy for the Development of Novel Treatments for Infectious Diseases

Methods in Enzymology

Volumn 369, Issue , 2003, Pages 322-344

  Blondelle, Sylvie E ^a   Pinilla, Clemencia ^a   Boggiano, César ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIKETOPIPERAZINE DERIVATIVE; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; DIETHYLENETRIAMINE DERIVATIVE; ECHINOCANDIN B; EPITOPE; FLUCONAZOLE; FLUCYTOSINE; HETEROCYCLIC COMPOUND; KETOCONAZOLE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICONAZOLE; N BENZYLAMINOCYCLIC UREA DERIVATIVE; NATAMYCIN; NONAPEPTIDE; PEPTIDE DERIVATIVE; PEPTIDE LIBRARY; PNEUMOCANDIN DERIVATIVE; PROTEIN P65[405-503]; PROTEINASE INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VACCINE; VANCOMYCIN; VIRUS ENVELOPE PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; BIOMETRY; CANDIDA ALBICANS; CELL FUNCTION; CELL POPULATION; COLONY FORMING UNIT; COMBINATORIAL LIBRARY; CROSS REACTION; CRYPTOCOCCUS NEOFORMANS; DRUG ACTIVITY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; FUNGICIDAL ACTIVITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LYMPHOCYTE ACTIVATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOSIS; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; SIDE EFFECT; T LYMPHOCYTE; VIRUS TRANSMISSION;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 0347478192     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(03)69018-X     Document Type: Article

References (65)

1. J. T. Cross, Jr. and G. D. Campbell, Jr., Clin. Chest Med. 20, 499 (1999).
2. C. O. Solberg, Scand. J. Infect. Dis. 32, 587 (2000).
3. K. Hiramatsu, Lancet Infect. Dis. 1, 147 (2001).
4. J. Ponton, R. Ruchel, K. V. Clemons, D. C. Coleman, R. Grillot, J. Guarro, D. Aldebert, P. Ambroise-Thomas, J. Cano, A. J. Carrillo-Munoz, J. Gene, C. Pinel, D. A. Stevens, and D. J. Sullivan, Med. Mycol. 38, 225 (2000).
5. Z. Temesgen, Expert Opin. Pharmacother. 2, 1239 (2001).
6. R. P. van Heeswijk, A. Vedkamp, J. W. Mulder, P. L. Meenhorst, J. M. Lange, J. H. Beijnen, and R. M. Hoetelmans, Antiviral Ther. 6, 201 (2001).
7. D. Pillay, Antiviral Ther. 6, 15 (2001).
8. C. Vigouroux, S. Gharakhanian, Y. Salhi, T. H. Nguyen, N. Adda, W. Rozenbaum, and J. Capeau, Diabetes Metab. 25, 383 (1999).
9. R. A. Houghten, C. Pinilla, J. R. Appel, S. E. Blondelle, C. T. Dooley, J. Eichler, A. Nefzi, and J. M. Ostresh, J. Med. Chem. 42, 3743 (1999).
10. S. E. Blondelle and K. Lohner, Biopolymers (Peptide Sci.) 55, 74 (2000).
11. R. A. Owens, P. D. Gesellchen, B. J. Houchins, and R. D. DiMarchi, Biochem. Biophys. Res. Commun. 181, 402 (1991).
12. T. A. Rano, Y. Cheng, T. T. Huening, F. Zhang, W. A. Schleif, L. Gabryelski, D. B. Olsen, L. C. Kuo, J. H. Lin, X. Xu, T. V. Olah, D. A. McLoughlin, R. King, K. T. Chapman, and J. R. Tata, Bioorg. Med. Chem. Lett. 10, 1527 (2000).
13. R. A. P. Lutzke, N. A. Eppens, P. A. Weber, R. A. Houghten, and R. H. Plasterk, Proc. Natl. Acad. Sci. USA 92, 11456 (1995).
14. R. A. Houghten, C. Pinilla, S. E. Blondelle, J. R. Appel, C. T. Dooley, and J. H. Cuervo, Nature 354, 84 (1991).
15. C. Pinilla, J. R. Appel, P. Blanc, and R. A. Houghten, Biotechniques 13, 901 (1992).
16. W. G. Powderly, K. H. Mayer, and J. R. Perfect, AIDS Res. Hum. Retroviruses 15, 1405 (1999).
17. K. J. Kwon-Chung, T. C. Sorrell, F. Dromer, E. Fung, and S. M. Levitz, Med. Mycol. 38, 205 (2000).
18. S. E. Blondelle, A. Nefzi, J. M. Ostresh, and R. A. Houghten, Pure Appl. Chem. 70, 2141 (1998).
19. S. E. Blondelle, E. Crooks, J. M. Ostresh, and R. A. Houghten, Antimicrob. Agents Chemother. 43, 106 (1999).
20. H. J. Roth and A. Kleeman, "Pharmaceutical Chemistry." John Wiley & Sons, New York, 1988.
21. A. Nefzi, J. M. Ostresh, J.-P. Meyer, and R. A. Houghten, Tetrahedron Lett. 38, 931 (1997).
22. C. E. Hoesl, A. Nefzi, J. M. Ostresh, Y. Yu, and R. A. Houghten, Chapter 25, this volume.
23. J. P. Metlay, Curr. Opin. Infect. Dis. 15, 163 (2002).
24. F. M. Hussain, S. Boyle-Vavra, and R. S. Daum, Pediatr. Infect. Dis. J. 20, 763 (2001).
25. J. M. Boyce, J. Hosp. Infect. 48, S9 (2001).
26. J. F. Acar and F. W. Goldstein, Clin. Infect. Dis. 24, S67 (1997).
27. R. Wilson and R. B. Dowling, Thorax 53, 213 (1998).
28. A. L. Brennan and D. M. Geddes, Curr. Opin. Infect. Dis. 15, 175 (2002).
29. T. Köhler, M. Michea-Hamzehpour, P. Plesiat, A.-L. Kahr, and J.-C. Pechere, Antimicrob. Agents Chemother. 41, 2540 (1997).
30. D. Finzi, J. Blankson, J. D. Siliciano, J. B. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. C. Quinn, R. E. Chaisson, E. Rosenberg, B. D. Walker, S. Gange, J. Gallant, and R. F. Siliciano, Nat. Med. 5, 512 (1999).
31. N. L. Michael and J. P. Moore, Nat. Med. 5, 740 (1999).
32. J. Martinez-Picado, M. P. DePasquale, N. Kartsonis, G. J. Hanna, J. Wong, D. Finzi, E. Rosenberg, H. F. Gunthard, L. Sutton, A. Savara, C. J. Petropoulos, N. Hellmann, B. D. Walker, D. D. Richman, R. Siliciano, and R. T. D'Aquila, Proc. Natl. Acad. Sci. USA 97, 10948 (2000).
33. C. Wild, T. Oas, V. McDanal, D. Bolognesi, and T. Matthews, Proc. Natl. Acad. Sci. USA 89, 10537 (1992).
34. S. Jiang, K. Lin, N. Strick, and A. R. Neurath, Nature 365, 113 (1993).
35. W. A. Weissenhorn, A. Dessen, S. C. Harrison, J. J. Skehel, and D. C. Wiley, Nature 387, 426 (1997).
36. D. C. Chan and P. S. Kim, Cell 93, 681 (1998).
37. P. D. Kwong, R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson, Nature 393, 648 (1998).
38. E. A. Berger, P. M. Murphy, and J. M. Farber, Annu. Rev. Immunol. 17, 657 (1999).
39. D. C. Chan, C. T. Chutkowski, and P. S. Kim, Proc. Natl. Acad. Sci. USA 95, 15613 (1998).
40. C. C. Broder and E. A. Berger, Proc. Natl. Acad. Sci. USA 92, 9004 (1995).
41. O. Nussbaum, C. C. Broder, and E. A. Berger, J. Virol. 68, 5411 (1994).
42. J. M. Ostresh, G. M. Husar, S. E. Blondelle, B. Dörner, P. A. Weber, and R. A. Houghten, Proc. Natl. Acad. Sci. USA 91, 11138 (1994).
43. A. Nefzi, J. M. Ostresh, and R. A. Houghten, Tetrahedron 55, 335 (1999).
44. A. Nefzi, M. A. Giulianotti, and R. A. Houghten, Tetrahedron 56, 3319 (2000).
45. B. R. Gundlach, K.-H. Wiesmüller, T. Junt, S. Kienle, G. Jung, and P. Walden, J. Immunol. Methods 192, 149 (1996).
46. C. Pinilla, R. Martin, B. Gran, J. R. Appel, C. Boggiano, D. B. Wilson, and R. A. Houghten, Curr. Opin. Immunol. 11, 193 (1999).
47. B. Hemmer, B. Gran, Y. Zhao, A. Marques, J. Pascal, A. Tzou, T. Kondo, I. Cortese, B. Bielekova, S. Straus, H. F. McFarland, R. A. Houghten, R. Simon, C. Pinilla, and R. Martin, Nat. Med. 5, 1375 (1999).
48. D. B. Wilson, C. Pinilla, D. H. Wilson, K. Schroder, C. Boggiano, V. Judkowski, J. Kaye, B. Hemmer, R. Martin, and R. A. Houghten, J. Immunol. 163, 6424 (1999).
49. B. Hemmer, C. Pinilla, B. Gran, M. Vergelli, N. Ling, P. Conlon, H. F. McFarland, R. A. Houghten, and R. Martin, J. Immunol. 164, 861 (2000).
50. R. Martin, B. Gran, Y. Zhao, S. Markovic-Plese, B. Bielekova, A. Marques, M. H. Sung, B. Hemmer, R. Simon, H. F. McFarland, and C. Pinilla, J. Autoimmun. 16, 187 (2001).
51. C. Pinilla, V. Rubio-Godoy, V. Dutoit, P. Guillaume, R. Simon, Y. Zhao, R. A. Houghten, J.-C. Cerottini, P. Romero, and D. Valmori, Cancer Res. 61, 5153 (2001).
52. C. La Rosa, R. Krishnan, S. Markel, J. P. Schneck, R. Houghten, C. Pinilla, and D. J. Diamond, Blood 97, 1776 (2001).
53. V. Rubio-Godoy, C. Pinilla, V. Dutoit, E. Borras, R. Simon, Y. Zhao, J.-C. Cerottini, P. Romero, R. A. Houghten, and D. Valmori, Cancer Res. 62, 2058 (2002).
54. D. Salmon-Ceron, HIV Med. 2, 255 (2001).
55. M. P. Weekes, M. R. Wills, K. Mynard, A. J. Carmichael, and J. G. Sissons, J. Virol. 73, 2099 (1999).
56. A. Solache, C. L. Morgan, A. I. Dodi, C. Morte, I. Scott, C. Baboonian, B. Zal, J. Goldman, J. E. Grundy, and J. A. Madrigal, J. Immunol. 163, 5512 (1999).
57. R. D. Salter, D. N. Howell, and P. Cresswell, Immunogenetics 21, 235 (1985).
58. H.-G. Rammensee, T. Friede, and S. Stevanovic, Immunogenetics 41, 178 (1995).
59. C. Pinilla, J. R. Appel, and R. A. Houghten, in "Current Protocols in Immunology" (J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds.), p. 9.5.1. John Wiley & Sons, New York, 2001.
60. V. Judkowski, C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson, J. Immunol. 166, 908 (2001).
61. M. Hagmann, Science 290, 80 (2000).
62. T. Sturniolo, E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, U. Sahin, M. Braxenthaler, F. Gallazzi, M. P. Protti, F. Sinigaglia, and J. Hammer, Nat. Biotechnol. 17, 555 (1999).
63. V. Brusic, J. Zeleznikow, and N. Petrovsky, J. Immunol. Methods 238, 17 (2000).
64. Y. Zhao, B. Gran, C. Pinilla, S. Markovic-Plese, B. Hemmer, A. Tzou, L. W. Whitney, W. E. Biddison, R. Martin, and R. Simon, J. Immunol. 167, 2130 (2001).
65. C. Boggiano, C. Pinilla, B. D. Walker, and S. E. Blondelle, in "Peptides: The Wave of the Future. Proceedings of the 2nd International/17th American Peptide Symposium" (R. A. Houghten and M. Lebl, eds.), p. 1023. Kluwer Academic Publishers, Norwell and Dordrecht, 2001.